Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Blanchard

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Demography|November 22, 2000
Intra-ethnic diversity in Hispanic child mortality, 1890-1910M P Gutmann, M R Haines, W P Frisbie, et al.
Current Issues in Molecular Biology|July 27, 2001
Ribozyme pharmacokinetic screening for predicting pharmacodynamic dosing regimensT J Parry, K S Bouhana, K S Blanchard, et al.
Hepatology (Baltimore, Md.)|August 29, 2000
Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in miceP A Lee, L M Blatt, K S Blanchard, et al.
Journal of Clinical Pharmacology|February 24, 2001
Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYME) in healthy volunteersJ A Sandberg, V P Parker, K S Blanchard, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkeyJ A Sandberg, C D Sproul, K S Blanchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptorsP A Pavco, K S Bouhana, A M Gallegos, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Demography|November 22, 2000
Intra-ethnic diversity in Hispanic child mortality, 1890-1910M P Gutmann, M R Haines, W P Frisbie, et al.
Current Issues in Molecular Biology|July 27, 2001
Ribozyme pharmacokinetic screening for predicting pharmacodynamic dosing regimensT J Parry, K S Bouhana, K S Blanchard, et al.
Hepatology (Baltimore, Md.)|August 29, 2000
Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in miceP A Lee, L M Blatt, K S Blanchard, et al.
Journal of Clinical Pharmacology|February 24, 2001
Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYME) in healthy volunteersJ A Sandberg, V P Parker, K S Blanchard, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkeyJ A Sandberg, C D Sproul, K S Blanchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptorsP A Pavco, K S Bouhana, A M Gallegos, et al.
Pageof 1